Paclitaxel (intraperitoneal)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Paclitaxel (intraperitoneal), covering 2021-03-15 to 2025-09-02. Get the full timeline:
Most recent: Clinical Trial Update: Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma [Phase 1, Phase 2]